Fusion Protein Promising for Patients With Refractory Recurrent Pericarditis

(MedPage Today) -- Study Authors: Allan L. Klein, Massimo Imazio, et al.Target Audience and Goal Statement: Cardiologists, rheumatologistsThe goal was to assess the outcomes from a phase III trial of the recombinant fusion protein rilonacept...